Among patients with lung adenocarcinoma, the most common mutations affecting the EGFR gene can be classified into four types: point mutations in exon 18, deletions in exon 19, insertions in exon 20, and point mutations in exon 21 [16] (Figure 3). This evidence concerns the gene EGFR and lung adenocarcinoma.